Tratamento da leishmaniose cutanea difusa (LCD) com a associacao antimoniato-N-metilglucamina (Glucantime®) e sulfato de paramomicina (Gabbrox®)
Nenhuma Miniatura disponível
Data
1999-01-01
Autores
Costa, Jackson Maurício L.
Mendes, Sandra
Melo, Luciana S.
Figueredo, Ivan
Rebêlo, José Manuel M. [UNESP]
Saldanha, Ana Cristina R.
Alves Gama, Mônica Elinor
Barral, Aldina
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Diffuse cutaneous leishmaniasis (DCL) is a rare form of tegumentary leishmaniasis (TL) and 350 cases have been reported world wide. Presently in Brazil, there were 31 cases reported corresponding to 8.9% of the world cases. The state of Maranhao contributed with ten cases (32.3%) of national reports. Recently the authors had opportunity to follow two new cases of DCL, both from the countryside of that state totaling 12 cases. The parasite Leishmania L. amazonensis was incriminated in the disease, confirming the available data as being the unique species to produce DCL in this state. The therapy associating meglumine anthimoniate with paramomicine sulphate (Gabbrox®) during 90 days, showed good tolerance and favorable response, being another option for fills form of DCL that constituted a challenge to science so far.
Descrição
Palavras-chave
Brazil, Cutaneous, Leishmaniasis, meglumine antimonate, paromomycin, adolescent, case report, female, human, leishmania, skin leishmaniasis
Como citar
Anais Brasileiros de Dermatologia, v. 74, n. 1, p. 63-67, 1999.